Back
  • Publish Date: Posted 4 months ago
  • Author: Sarah Seaford
​🎉 Exciting news from the world of biotech! bit.bio has just secured $50M in Series C funding, led by M&G Investments, to scale their human cell programming technology.

This funding turbocharges the development of the ioCells platform, enabling more predictive, human-relevant pre-clinical models, supporting AI-driven research, and moving us closer to reducing reliance on animal testing.

So inspired by how innovation like this is shaping the future of drug discovery. Big things ahead! 🚀 https://hubs.ly/Q03-8xjd0

Read the full announcement